{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:56:56Z","timestamp":1773773816999,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005982.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000}}],"reference-count":83,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005982.pub3","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T22:42:35Z","timestamp":1592433755000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children"],"prefix":"10.1002","volume":"2020","author":[{"given":"Marie-Claude","family":"Pelland-Marcotte","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation; University of Toronto; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Amiri","sequence":"additional","affiliation":[{"name":"Division of Haematology-Oncology; The Hospital for Sick Children; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L","family":"Avila","sequence":"additional","affiliation":[{"name":"Division of Haematology-Oncology; The Hospital for Sick Children; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo R","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Division of Haematology-Oncology; The Hospital for Sick Children; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"2-3","key":"10.1002\/14651858.CD005982.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0003|cit3","first-page":"654","article-title":"Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial","volume":"92","author":"Abdelkefi","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0004|cit4","first-page":"1","article-title":"Evaluating the effect of high dose versus low dose heparin in peripherally inserted central catheter in very low birth weight infants","volume":"28","author":"Behzad","year":"2018","journal-title":"Iranian Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.thromres.2009.03.004","article-title":"Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications","volume":"125","author":"Cavo","year":"2010","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/S0959-8049(17)30534-8","article-title":"Is there a role for antithrombotic prophylaxis in oncologic patients who undergo central venous access placement?","volume":"72 (Supplement","author":"Cefali","year":"2017","journal-title":"European Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD005982.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/annonc\/mdp235","article-title":"Early and short-term acenocumarine or dalteparin for the prevention of central venous catheter-related thrombosis in cancer patients: a randomized controlled study based on venographies","volume":"20","author":"De Cicco","year":"2009","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0008|cit8","first-page":"s136","article-title":"Factors that increase the risk of central venous catheter-related thrombosis in acute myeloid leukemia: a prospective, randomized experience","volume":"10","author":"Del Principe","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpeds.2018.02.039","article-title":"Catheter-related venous thrombosis in hospitalized pediatric patients with inflammatory bowel disease: incidence, characteristics, and role of anticoagulant thromboprophylaxis with enoxaparin","volume":"198","author":"Diamond","year":"2018","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.thromres.2010.04.013","article-title":"Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment","volume":"126","author":"Harlev","year":"2010","journal-title":"Thrombosis Research"},{"issue":"6","key":"10.1002\/14651858.CD005982.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1043454210369895","article-title":"Observational cohort study of pediatric inpatients with central venous catheters at \"intermediate risk\" of thrombosis and eligible for anticoagulant\u00a0prophylaxis","volume":"27","author":"Harney","year":"2010","journal-title":"Journal of Pediatric Oncology Nursing"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/annonc\/mdj059","article-title":"Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial","volume":"17","author":"Karthaus","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"iii286","DOI":"10.1093\/ndt\/gfx150.SP477","article-title":"Tin-cat study: Conversion of unfractionned heparin to tinzaparin in hemodialysis and its impact on alteplase (cathflo) utilization","volume":"32 (Supplement","author":"Korkemaz","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD005982.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/nep.12681","article-title":"Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: a randomized cross-over trial","volume":"21","author":"Kurtkoti","year":"2016","journal-title":"Nephrology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0015|cit15","first-page":"A4464","article-title":"Risk of thromboses from peripherally inserted central catheters (PICCs) in the ICU","volume":"189","author":"Lamontagne","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-013-2169-y","article-title":"Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study","volume":"72","author":"Lavau-Denes","year":"2013","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"12","key":"10.1002\/14651858.CD005982.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.4314\/tjpr.v15i12.28","article-title":"Anticoagulant effect of low molecular weight heparin on central venous catheters in haemodialysis patients","volume":"15","author":"Li","year":"2016","journal-title":"Tropical Journal of Pharmaceutical Research"},{"issue":"12","key":"10.1002\/14651858.CD005982.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00467-018-4032-1","article-title":"Dalteparin anticoagulation in paediatric home haemodialysis","volume":"33","author":"Lutkin","year":"2018","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"335A","DOI":"10.1203\/00006450-198404001-01450","article-title":"Heparin prevention of catheter related thromboses","volume":"18","author":"McDonald","year":"1984","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0020|cit20","first-page":"67","article-title":"Low molecular weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial","volume":"88","author":"Mismetti","year":"2003","journal-title":"Haematologica"},{"issue":"24","key":"10.1002\/14651858.CD005982.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","article-title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study","volume":"115","author":"Mitchell","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1538-7836.2007.02660.x","article-title":"Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study","volume":"5","author":"Niers","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0024|cit24","unstructured":"Pardun N Lemmer J Belker K Pringsheim M Hager A Ewert P Low molecular weight heparin administered by subcutaneous catheter is a safe and effective anticoagulation regimen in selected inpatient infants and children with complex congenital heart disease Cardiology in the Young 2017 S460"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1542\/peds.2010-3282","article-title":"Thromboprophylaxis in a pediatric hospital: A patient-safety and quality-improvement initiative","volume":"127","author":"Raffini","year":"2011","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0026|cit26","unstructured":"Efficacy and safety of prophylaxis with bemiparin in cancer patients with a central venous catheter (BECAT) clinicaltrials.gov\/ct2\/show\/NCT00311896"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jvs.2007.11.054","article-title":"Incidence, risk factors and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk","volume":"47","author":"Sandoval","year":"2008","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0028|cit28","first-page":"S71","article-title":"Dalteparin is a safe and effective alternative to unfractionated heparin for extra-corporeal anti coagulation","volume":"26 (8 Supplemen","author":"Thirunavukkarasu","year":"2016","journal-title":"Indian Journal of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1538-7836.2010.03964.x","article-title":"Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study","volume":"8","author":"Trame","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD005982.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.thromres.2010.08.027","article-title":"Catheter-related thrombosis in children with intestinal failure and long-term parenteral nutrition: how to treat and to prevent?","volume":"126","author":"Ommen","year":"2010","journal-title":"Thrombosis Research"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0148607111416482","article-title":"Prophylactic anticoagulation decreases catheter-related thrombosis and occlusion in children with home parenteral nutrition","volume":"36","author":"Vegting","year":"2012","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"18","key":"10.1002\/14651858.CD005982.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for prevention of thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11239-019-01844-7","article-title":"Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients","volume":"47","author":"Wang","year":"2019","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12887-017-0877-x","article-title":"TropicALL study: Thromboprophylaxis in children treated for Acute Lymphoblastic Leukemia with low-molecular-weight heparin: a multicenter randomized controlled trial","volume":"17","author":"Klaassen","year":"2017","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0035|cit35","unstructured":"Prevention of central venous catheter-associated thrombosis in critically ill children: a multicenter phase 2b trial clinicaltrials.gov\/ct2\/show\/NCT03003390"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","article-title":"Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-3476(95)70448-5","article-title":"A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home","volume":"126","author":"Andrew","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2001-14548","article-title":"Venous thromboembolism in pediatrics","volume":"1","author":"Anton","year":"2001","journal-title":"Seminars in Vascular Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0040|cit40","first-page":"677","article-title":"Management of cutaneous reactions and mechanical complications of central venous access devices in pediatric patients with cancer: algorithms for decision making","volume":"17","author":"Bagnall-Reeb","year":"1990","journal-title":"Oncology Nursing Forum"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9684","key":"10.1002\/14651858.CD005982.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(09)60220-8","article-title":"Management of occlusion and thrombosis associated with long-term indwelling central venous catheters","volume":"374","author":"Baskin","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00063198-200309000-00004","article-title":"Central line thrombosis in patients with cancer","volume":"9","author":"Bona","year":"2003","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010996.pub3","article-title":"Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children","author":"Bradford","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005982.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0277-5379(89)90151-X","article-title":"Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors","volume":"25","author":"Carde","year":"1989","journal-title":"European Journal of Cancer and Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08543.x","article-title":"Guidelines on the investigation, management and prevention of venous thrombosis in children","volume":"154","author":"Chalmers","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0047|cit47","unstructured":"Committee for proprietary medicinal products (CPMP) Notes for guidance on clinical investigation of medicinal products for treatment of venous thromboembolic disease (2016) www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-clinical-investigation-medicinal-products-treatment-venous-thromboembolic-disease_en.pdf"},{"issue":"22","key":"10.1002\/14651858.CD005982.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Advances"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/CCM.0000000000000147","article-title":"PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet. A multinational study of thromboprophylaxis practice in critically ill children","volume":"42","author":"Faustino","year":"2014","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1603938","article-title":"Central venous catheter-associated deep venous thrombosis in critically ill children","volume":"44","author":"Faustino","year":"2018","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/08880010490457042","article-title":"Central venous line thrombosis in children and young adults with thalassemia major","volume":"21","author":"Finkelstein","year":"2004","journal-title":"Pediatric Hematology and Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/annonc\/mdi111","article-title":"Central venous catheter-related complications in children with oncological\/hematological diseases: an observational study of 418 devices","volume":"16","author":"Fratino","year":"2005","journal-title":"Annals of Oncology"},{"issue":"7651","key":"10.1002\/14651858.CD005982.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"Quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0054|cit54","unstructured":"Higgins JP Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD005982.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006650.pub5","article-title":"Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer","author":"Kahale","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"16","key":"10.1002\/14651858.CD005982.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/archinte.163.16.1913","article-title":"Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review","volume":"163","author":"Klerk","year":"2003","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-3476(95)70499-X","article-title":"Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding","volume":"126","author":"Krafte-Jacobs","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-155-9-201111010-00008","article-title":"Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline","volume":"155","author":"Lederle","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2005.03.5600","article-title":"Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer","volume":"24","author":"Lee","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0060|cit60","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1378\/chest.119.1_suppl.108S","article-title":"Hemorrhagic complications of anticoagulant treatment","volume":"119","author":"Levine","year":"2001","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD005982.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008462.pub3","article-title":"Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults","author":"L\u00f3pez-Briz","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD005982.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2002-09-2731","article-title":"Central venous line-related thrombosis in children: association with central venous line location and insertion technique","volume":"101","author":"Male","year":"2003","journal-title":"Blood"},{"issue":"13","key":"10.1002\/14651858.CD005982.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1200\/JCO.2005.12.097","article-title":"Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement","volume":"23","author":"McLean","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21222","article-title":"Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia","volume":"50","author":"Meister","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD005982.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1538-7836.2011.04433.x","article-title":"Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children","volume":"9","author":"Mitchell","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD005982.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0069|cit69","unstructured":"Combination chemotherapy based on risk of relapse in treating young patients with acute lymphoblastic leukemia clinicaltrials.gov\/ct2\/show\/NCT00430118"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0070|cit70","unstructured":"International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia clinicaltrials.gov\/ct2\/show\/NCT01117441"},{"issue":"5","key":"10.1002\/14651858.CD005982.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V93.5.1595","article-title":"Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors","volume":"93","author":"Nowak-G\u00f6ttl","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PCC.0b013e3181f36bd9","article-title":"In the absence of a central venous catheter, risk of venous thromboembolism is low in critically injured children, adolescents, and young adults: evidence from the National Trauma Data Bank","volume":"12","author":"O'Brien","year":"2011","journal-title":"Pediatric Critical Care Medicine"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0073|cit73","unstructured":"OpenEpi: Open Source Epidemiologic Statistics for Public Health Dean AG Sullivan KM Soe MM"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD005982.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1378\/chest.113.1.165","article-title":"Benefit of heparin in central venous and pulmonary artery catheters:a meta-analysis of randomized controlled trials","volume":"113","author":"Randolph","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD005982.pub3-BIB0076|cit76","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD005982.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002772.pub3","article-title":"Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters","author":"Shah","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1553-2712.2001.tb01292.x","article-title":"Central line mechanical complication rate in emergency medicine patients","volume":"8","author":"Steele","year":"2001","journal-title":"Academic Emergency Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005982.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jth.12598","article-title":"Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis","volume":"12","author":"Vidal","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2141.1999.01222.x","article-title":"Central venous catheter-associated thrombosis in severe haemophilia","volume":"104","author":"Vidler","year":"1999","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD005982.pub3-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005982.pub2","article-title":"Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children","author":"Brandao","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005982.pub3-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005982","article-title":"Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children","author":"Shah","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T07:47:31Z","timestamp":1644824851000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005982.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005982.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}